CNS Pharmaceuticals CNSP Stock
7.7 USD
{{ price }}
2.529954%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
Tech Market Small
Market Cap
4.42M USD
LOW - HIGH [24H]
7.26
-
7.75 USD
VOLUME [24H]
8.36K USD
{{ volume }}
P/E Ratio
0.0036
Earnings per share
2131.86 USD
CNS Pharmaceuticals Price Chart
CNS Pharmaceuticals CNSP Financial and Trading Overview
| CNS Pharmaceuticals stock price | 7.7 USD |
| Previous Close | 0.9 USD |
| Open | 0.84 USD |
| Bid | 0.76 USD x 100 |
| Ask | 0.84 USD x 100 |
| Day's Range | 0.8 - 0.84 USD |
| 52 Week Range | 0.73 - 62 USD |
| Volume | 511.69K USD |
| Avg. Volume | 1.72M USD |
| Market Cap | 4.37M USD |
| Beta (5Y Monthly) | 0.782 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 2131.86 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7 USD |
CNSP Valuation Measures
| Enterprise Value | -8330809 USD |
| Trailing P/E | N/A |
| Forward P/E | -2.0512822 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.21470746 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.531 |
Trading Information
CNS Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.782 |
| 52-Week Change | -98.49% |
| S&P500 52-Week Change | 13.16% |
| 52 Week High | 62 USD |
| 52 Week Low | 0.73 USD |
| 50-Day Moving Average | 0.99 USD |
| 200-Day Moving Average | 3.54 USD |
CNSP Share Statistics
| Avg. Volume (3 month) | 1.72M USD |
| Avg. Daily Volume (10-Days) | 158.5K USD |
| Shares Outstanding | 5.46M |
| Float | 5.44M |
| Short Ratio | 0.11 |
| % Held by Insiders | 0.21% |
| % Held by Institutions | 1.13% |
| Shares Short | 461.11K |
| Short % of Float | 8.43% |
| Short % of Shares Outstanding | 8.43% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | March 31, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -127.30% |
| Return on Equity (ttm) | -477.53% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -15691161 USD |
| Net Income Avi to Common (ttm) | -15614373 USD |
| Diluted EPS (ttm) | -924.6 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.05M USD |
| Total Cash Per Share (mrq) | 2.39 USD |
| Total Debt (mrq) | 210.67K USD |
| Total Debt/Equity (mrq) | 1.92 USD |
| Current Ratio (mrq) | 4.937 |
| Book Value Per Share (mrq) | 3.726 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17163148 USD |
| Levered Free Cash Flow (ttm) | -12319404 USD |
Profile of CNS Pharmaceuticals
| Country | United States |
| State | TX |
| City | Houston |
| Address | 2100 West Loop South |
| ZIP | 77027 |
| Phone | 800-946-9185 |
| Website | https://www.cnspharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Q&A For CNS Pharmaceuticals Stock
What is a current CNSP stock price?
CNS Pharmaceuticals CNSP stock price today per share is 7.7 USD.
How to purchase CNS Pharmaceuticals stock?
You can buy CNSP shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CNS Pharmaceuticals?
The stock symbol or ticker of CNS Pharmaceuticals is CNSP.
Which industry does the CNS Pharmaceuticals company belong to?
The CNS Pharmaceuticals industry is Biotechnology.
How many shares does CNS Pharmaceuticals have in circulation?
The max supply of CNS Pharmaceuticals shares is 574.58K.
What is CNS Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
CNS Pharmaceuticals PE Ratio is 0.00361187 now.
What was CNS Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
CNS Pharmaceuticals EPS is 2131.86 USD over the trailing 12 months.
Which sector does the CNS Pharmaceuticals company belong to?
The CNS Pharmaceuticals sector is Healthcare.
CNS Pharmaceuticals CNSP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23724.96 USD — |
+0.61
|
9.88B USD — | 23628.82 USD — | 23946.23 USD — | — - | 9.88B USD — |
| US Tech Capital Market Composite RCMP | 138.63 USD — |
+1.56
|
— — | 136.28 USD — | 138.82 USD — | — - | — — |
| US Tech Health Care IXHC | 1115.96 USD — |
+0.87
|
— — | 1099.74 USD — | 1117.62 USD — | — - | — — |
- {{ link.label }} {{link}}